Vasowatch
Vasowatch is dedicated to improving maternal outcomes by developing innovative, non-invasive monitoring solutions for postpartum hemorrhage. Their mission is to enable early detection and risk prediction to save mothers' lives and enhance birth experiences globally.
Industries
Nr. of Employees
small (1-50)
Vasowatch
3401 Grays Ferry Ave Building 450-1068, Philadelphia, PA, 19146
Products
Continuous monitoring system for predicting postpartum hemorrhage
A monitoring system that combines non-invasive wearable sensors with cloud-based algorithmic analysis to compute a myometrial fatigue biomarker and generate clinician alerts during labor and delivery.
Continuous monitoring system for predicting postpartum hemorrhage
A monitoring system that combines non-invasive wearable sensors with cloud-based algorithmic analysis to compute a myometrial fatigue biomarker and generate clinician alerts during labor and delivery.
Services
Support for integrating the monitoring system into hospital hardware and clinical workflows, including dashboard deployment at bedside and nurse stations.
Collaboration for observational studies and validation of the heart-rate–based biomarker, including preparation and submission of technical manuscripts.
Support for integrating the monitoring system into hospital hardware and clinical workflows, including dashboard deployment at bedside and nurse stations.
Collaboration for observational studies and validation of the heart-rate–based biomarker, including preparation and submission of technical manuscripts.
Expertise Areas
- Maternal health monitoring and obstetrics-focused clinical support
- Digital health and cloud-based SaMD
- Biomarker development and physiological signal analysis
- Clinical decision support and real-time alerting
Key Technologies
- ECG and PPG wearable sensor integration
- Cloud-based medical software (SaMD)
- Real-time physiological data streaming
- Algorithmic risk scoring and biomarker computation
News & Updates
Vasowatch was selected to pitch at the Startup World Cup in Philadelphia.
Vasowatch was selected as a semi-finalist in MIT Solve’s 2025 Global Health Challenge.
Vasowatch was selected to participate in the HiveBio accelerator supporting underrepresented life science entrepreneurs.
Vasowatch was featured as one of the top healthcare innovators at MEDCity.
Vasowatch was a finalist and placed second in the Startup302 competition.
Vasowatch was selected to present at the Seed2Table Washington DC forum.
Vasowatch was selected to pitch at the Startup World Cup in Philadelphia.
Vasowatch was selected as a semi-finalist in MIT Solve’s 2025 Global Health Challenge.
Vasowatch was selected to participate in the HiveBio accelerator supporting underrepresented life science entrepreneurs.
Vasowatch was featured as one of the top healthcare innovators at MEDCity.
Vasowatch was a finalist and placed second in the Startup302 competition.
Vasowatch was selected to present at the Seed2Table Washington DC forum.